Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICLIN AG Earnings Release 2010

Mar 3, 2011

280_rns_2011-03-03_8eda25e5-f4c3-41be-b4df-224a3a202633.html

Earnings Release

Open in viewer

Opens in your device viewer

News Details

Corporate | 3 March 2011 08:30

MediClin AG: sales increased – result on previous years level

MediClin AG / Key word(s): Preliminary Results

03.03.2011 / 08:30

MediClin: sales increased – result on previous years level

Offenburg, March 3rd, 2011 – In 2010 MEDICLIN Aktiengesellschaft (MediClin) has increased Group sales by EUR 16.6 million or 3.5% up to EUR 487.2 million (2009: EUR 470.6 million). A preliminary Group-EBIT of EUR 16.9 million was achieved which was nearly on the previous year's level (2009: EUR 17.0 million) despite high investments. The preliminary comprehensive income attributable to shareholders of MediClin AG amounts to EUR 10.0 million (2009: EUR 10.3 million).

In 2010 a total number of 2.5 million nursing day was provided and close to 121 thousand cases were treated. The occupancy rate of the Group was with 86.6% on a high level, nevertheless did not accomplish the previous year's value (2009: 87.1%).

Result improved in the acute segment

Sales of both segments post acute and acute increased by 1.9% respectively 5.6%. The preliminary segment result of the post acute segment was on the previous year's level; the preliminary segment result of the acute segment was clearly above previous year's figure.

Material costs rose by 2.7% – the material cost quota was 22.6% (2009: 22.8%).

Personnel costs rose by 4.6%. The personnel cost quota was 54.8 % (2009: 54.2 %). The number of staff accounted in full time employees increased by 150 employees on average in 2010 and amounted to 5,984 full-time employees on average in 2010 (2009: 5,834 full-time employees).

Other operational expenses increased by EUR 2.9 million up to auf EUR 89.3 million (2009: EUR 86.4 million). Close to half of the increase resulted from higher maintenance expenses.

Investments (gross additions to property, plant and equipment) amounted to EUR 23.3 million EUR (2009: EUR 18.8 million).

The cash flow from operating activities was EUR 13.4 million (2009: EUR 32.3 Mio. EUR).

The balance press conference and the analyst conference will take place on March 24, 2011 in Frankfurt. As from that date the Annual Report 2010 will be available at www.mediclin.de .

Preliminary key data – FY 2010 and yoy comparison

in million € Q1 10 Q2 10 Q3 10 Q4 10 2010 2009
Group sales 118,2 122,8 122,0 124,2 487,2 470,6
Group operating result 0,0 4,9 7,2 4,8 16,9 17,0
Comprehensive income attributable to shareholders -1,6 3,1 4,7 3,8 10,0 10,3
Earnings per share in € (undiluted/diluted) -0,03 0,06 0,10 0,08 0,21 0,22
* 2009: 47,5 million shares / 2008: 47,25 million shares
in million € Q1 10 Q2 10 Q3 10 Q4 10 2010 2009
Post-acute
Sales 66,2 69,8 70,0 69,2 275,2 270,0
Segment result -2,0 2,8 4,3 1,0 6,2 6,2
Acute
Sales 49,2 50,0 48,9 52,2 200,3 189,6
Segment result 4,1 4,3 4,3 5,5 18,1 17,2
Other activities and reconciliation
Sales 2,8 3,0 3,1 2,8 11,7 11,0
thereof business area nursing care 2,8 2,7 2,8 2,9 11,2 11,3
Segment result -2,1 -2,2 -1,4 -1,8 -7,4 -6,4
(Due to arithmetical reasons, calculation differences may occur in the table above)

About MediClin AG (Ticker: MED; ISIN: DE0006595101)

MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,100 employees.

End of Corporate News


03.03.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Deutschland
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of News DGAP News-Service
- - -
114251  03.03.2011